Our software solutions

Medis Suite XA

The industry-leading, defacto standard and vendor-independent software solution for your coronary and ventricular X-Ray analyses.

Quantified Clinical Decisions

Validated results, and therefore applicable for coronary arteries, bifurcations, peripheral vessels and left and right ventricular functions.

Workflow Efficiency

One streamlined workflow for all modules, easy acquisition and analysis independent of X-Ray vendors.

Robust Platform

Robust Medis Suite Platform, which integrates browsing, analyzing and reporting and offers repository management and data handling.

What is Medis Suite XA?

Medis Suite XA is our solution for X-Ray angiography with an experience based on 30+ years of innovations in cardiovascular image analysis. Medis Suite XA is a complete package that provides various modules including a highly practical viewer, various coronary and vascular analyses that allow for anatomical evaluation of the arteries, various analyses for both left and right ventricles, as well as integrated reporting.

Over the past 30 years, 600+ papers have been published regarding Medis Suite XA
Medis Suite XA supports coronary, peripheral and ventricular angiograms of all major X-Ray vendors such as Philips, GE, Siemens, Canon and more.
Medis Suite XA can automatically load X-Ray images and visualize ECG signal, if available.
Medis Suite XA offers one streamlined workflow for all modules, so you can easily switch between different modules.

What's new in the latest version of Medis Suite XA

What our users are saying about Medis Suite XA.

“Medis Suite XA has proven to be very intuitive and easy to learn, even with the challenging cases in our large real-world population trial. It allows us to perform a high volume of quantitative angiographic analyses with limited personnel”.

Clemens von Birgelen, PD PhD Professor of Interventional Cardiology, University of Twente, Enschede, the Netherlands

“We have been using the Medis Suite XA software in our core laboratory since 1991. All major interventional device trials with angiographic endpoints have been evaluated using Medis Suite XA as the standard”.

Alexandra J. Lansky, MD Associate Professor of Clinical Medicine Director, Clinical Services, Center for Interventional Vascular Therapy Columbia University Medical Center